Stanislav Gobec
Stanislav Gobec
Faculty of Pharmacy, University of Ljubljana
Verified email at ffa.uni-lj.si - Homepage
Title
Cited by
Cited by
Year
Cytoplasmic steps of peptidoglycan biosynthesis
H Barreteau, A Kovač, A Boniface, M Sova, S Gobec, D Blanot
FEMS microbiology reviews 32 (2), 168-207, 2008
5392008
Discovery, biological evaluation, and crystal structure of a novel nanomolar selective butyrylcholinesterase inhibitor
B Brus, U Kosak, S Turk, A Pislar, N Coquelle, J Kos, J Stojan, JP Colletier, ...
Journal of medicinal chemistry 57 (19), 8167-8179, 2014
1302014
Inhibitors of cathepsin B
R Frlan, S Gobec
Current medicinal chemistry 13 (19), 2309-2327, 2006
1242006
Inhibitors of 17β-hydroxysteroid dehydrogenase type 1
S Gobec, P Brozic, TL Rizner
Current medicinal chemistry 15 (2), 137-150, 2008
972008
Discovery of novel 5-benzylidenerhodanine and 5-benzylidenethiazolidine-2, 4-dione inhibitors of MurD ligase
N Zidar, T Tomašić, R Šink, V Rupnik, A Kovac, S Turk, D Patin, ...
Journal of medicinal chemistry 53 (18), 6584-6594, 2010
952010
Structural and functional characterization of enantiomeric glutamic acid derivatives as potential transition state analogue inhibitors of MurD ligase
M Kotnik, J Humljan, C Contreras-Martel, M Oblak, K Kristan, M Hervé, ...
Journal of molecular biology 370 (1), 107-115, 2007
762007
Discovery of novel benzene 1, 3-dicarboxylic acid inhibitors of bacterial MurD and MurE ligases by structure-based virtual screening approach
A Perdih, A Kovač, G Wolber, D Blanot, S Gobec, T Solmajer
Bioorganic & medicinal chemistry letters 19 (10), 2668-2673, 2009
672009
5‐Benzylidenethiazolidin‐4‐ones as multitarget inhibitors of bacterial Mur ligases
T Tomašić, N Zidar, A Kovač, S Turk, M Simčič, D Blanot, ...
ChemMedChem: Chemistry Enabling Drug Discovery 5 (2), 286-295, 2010
662010
False positives in the early stages of drug discovery
R Sink, S Gobec, S Pecar, A Zega
Current medicinal chemistry 17 (34), 4231-4255, 2010
652010
Novel Naphthalene-N-sulfonyl-d-glutamic Acid Derivatives as Inhibitors of MurD, a Key Peptidoglycan Biosynthesis Enzyme,
J Humljan, M Kotnik, C Contreras-Martel, D Blanot, U Urleb, A Dessen, ...
Journal of medicinal chemistry 51 (23), 7486-7494, 2008
642008
Structural characterization and biological evaluation of a clioquinol–ruthenium complex with copper-independent antileukaemic activity
M Gobec, J Kljun, I Sosič, I Mlinarič-Raščan, M Uršič, S Gobec, I Turel
Dalton Transactions 43 (24), 9045-9051, 2014
612014
Nonsteroidal anti-inflammatory drugs and their analogues as inhibitors of aldo-keto reductase AKR1C3: new lead compounds for the development of anticancer agents
S Gobec, P Brožič, TL Rižner
Bioorganic & medicinal chemistry letters 15 (23), 5170-5175, 2005
612005
Phosphonate inhibitors of antigen 85C, a crucial enzyme involved in the biosynthesis of the Mycobacterium tuberculosis cell wall
S Gobec, I Plantan, J Mravljak, RA Wilson, GS Besra, D Kikelj
Bioorganic & medicinal chemistry letters 14 (13), 3559-3562, 2004
612004
Cinnamic acids as new inhibitors of 17β-hydroxysteroid dehydrogenase type 5 (AKR1C3)
P Brožič, B Golob, N Gomboc, TL Rižner, S Gobec
Molecular and cellular endocrinology 248 (1-2), 233-235, 2006
602006
Endocrine Disruptome An Open Source Prediction Tool for Assessing Endocrine Disruption Potential through Nuclear Receptor Binding
K Kolšek, J Mavri, M Sollner Dolenc, S Gobec, S Turk
Journal of chemical information and modeling 54 (4), 1254-1267, 2014
592014
Novel mechanism of cathepsin B inhibition by antibiotic nitroxoline and related compounds
B Mirković, M Renko, S Turk, I Sosič, Z Jevnikar, N Obermajer, D Turk, ...
ChemMedChem 6 (8), 1351-1356, 2011
572011
Discovery of new inhibitors of the bacterial peptidoglycan biosynthesis enzymes MurD and MurF by structure-based virtual screening
S Turk, A Kovač, A Boniface, JM Bostock, I Chopra, D Blanot, S Gobec
Bioorganic & medicinal chemistry 17 (5), 1884-1889, 2009
572009
Design, synthesis and structure–activity relationships of new phosphinate inhibitors of MurD
K Štrancar, D Blanot, S Gobec
Bioorganic & medicinal chemistry letters 16 (2), 343-348, 2006
562006
Design, synthesis, and evaluation of new thiadiazole-based direct inhibitors of enoyl acyl carrier protein reductase (InhA) for the treatment of tuberculosis
R Šink, I Sosič, M Živec, R Fernandez-Menendez, S Turk, S Pajk, ...
Journal of medicinal chemistry 58 (2), 613-624, 2015
542015
Development of new cathepsin B inhibitors: combining bioisosteric replacements and structure-based design to explore the structure–activity relationships of nitroxoline derivatives
I Sosič, B Mirković, K Arenz, B Štefane, J Kos, S Gobec
Journal of medicinal chemistry 56 (2), 521-533, 2013
532013
The system can't perform the operation now. Try again later.
Articles 1–20